Search research articles
Contact Us
Filters
Showing results (51-60 of 148) with videos related to
Page
of 15
Sort By:
Oncotarget
|
May 19, 2018
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Didier Decaudin, Rania El Botty, Béré Diallo, et al.
JAMA Ophthalmology
|
January 3, 2020
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival
Manuel Rodrigues, Khadija Ait Rais, Flore Salviat, et al.
Cancers
|
May 16, 2023
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
Malcy Tarin, Fariba Némati, Didier Decaudin, et al.
Pigment Cell & Melanoma Research
|
February 1, 2017
Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts
Ronan Crépin, David Gentien, Angeline Duché, et al.
Bulletin Du Cancer
|
March 27, 2025
Chondrosarcomas: Multidisciplinary review and practical recommendations, on behalf of GroupOs
Pascaline Boudou-Rouquette, Nadège Corradini, Marie-Pierre Sunyach, et al.
Oncotarget
|
August 11, 2016
Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
Guillaume Carita, Estelle Frisch-Dit-Leitz, Ahmed Dahmani, et al.
Plos One
|
January 24, 2014
Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts
Fariba Némati, Catherine de Montrion, Guillaume Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2012
Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma
Jordan Madic, Sophie Piperno-Neumann, Vincent Servois, et al.
Targeted Oncology
|
November 13, 2013
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial
Nicolas Penel, Isabelle Ray-Coquard, Christine Bal-Mahieu, et al.
The Journal of Pathology. Clinical Research
|
June 20, 2018
Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases
Raymond Barnhill, Peter Vermeulen, Sofie Daelemans, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 148) with videos related to
Sort By:
Page
of 15
Oncotarget
|
May 19, 2018
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Didier Decaudin, Rania El Botty, Béré Diallo, et al.
JAMA Ophthalmology
|
January 3, 2020
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival
Manuel Rodrigues, Khadija Ait Rais, Flore Salviat, et al.
Cancers
|
May 16, 2023
FAK Inhibitor-Based Combinations with MEK or PKC Inhibitors Trigger Synergistic Antitumor Effects in Uveal Melanoma
Malcy Tarin, Fariba Némati, Didier Decaudin, et al.
Pigment Cell & Melanoma Research
|
February 1, 2017
Nanobodies against surface biomarkers enable the analysis of tumor genetic heterogeneity in uveal melanoma patient-derived xenografts
Ronan Crépin, David Gentien, Angeline Duché, et al.
Bulletin Du Cancer
|
March 27, 2025
Chondrosarcomas: Multidisciplinary review and practical recommendations, on behalf of GroupOs
Pascaline Boudou-Rouquette, Nadège Corradini, Marie-Pierre Sunyach, et al.
Oncotarget
|
August 11, 2016
Dual inhibition of protein kinase C and p53-MDM2 or PKC and mTORC1 are novel efficient therapeutic approaches for uveal melanoma
Guillaume Carita, Estelle Frisch-Dit-Leitz, Ahmed Dahmani, et al.
Plos One
|
January 24, 2014
Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts
Fariba Némati, Catherine de Montrion, Guillaume Lang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2012
Pyrophosphorolysis-activated polymerization detects circulating tumor DNA in metastatic uveal melanoma
Jordan Madic, Sophie Piperno-Neumann, Vincent Servois, et al.
Targeted Oncology
|
November 13, 2013
Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial
Nicolas Penel, Isabelle Ray-Coquard, Christine Bal-Mahieu, et al.
The Journal of Pathology. Clinical Research
|
June 20, 2018
Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases
Raymond Barnhill, Peter Vermeulen, Sofie Daelemans, et al.
Page
of 15